Assessment of jadwar capsule on clinical manifestation of knee Osteoarthritis
- Conditions
- knee osteoarthritis.Osteoarthritis of knee
- Registration Number
- IRCT20181218042037N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 94
Mild to moderate knee Ostoarthritis patients according to Kellegren-Lawrence (K-L) grading scale
Pain at least in one knee in last 3 month ago
Minimum annoying pain (at least 4 ) before randomized selection according to VAS scale
Allergy to oral consumption of jadwar capsul.
Secondary Osteoarthritis as Rhuomatoid arthritis,Gout,Infectious arthritis,Metabolic arthritis,Traumatic arthritis.
Operative knee joint replacement .
Topical or systemic steroid use since 14 day before study .
Intraarticular steroid injection since 90 day before study .
Pregnancy and lactation period .
Alcohol and opioid addiction
Radiculopathy and Neuropathy .
History of any kind of knee operation and trauma
Utilization of other analgesic drugs since study period
History of renal failure or heart failure or hepatic failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of knee pain intensity. Timepoint: Measuring the Score of knee pain intensity at the beginning of the study and 14 and 28 days after starting use of jadwar capsul. Method of measurement: Visual Analogue Scale.;Daily activity Score. Timepoint: Measuring of Daily activity Score at the beginning of the study and 14 and 28 days after starting use of jadwar capsul. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis questionnaire.
- Secondary Outcome Measures
Name Time Method